Whirlwind Week As German Medtechs Ponder Trump Effect And Whither Domestic Government
On Eve Of Medica, Industry Concern At Evolving Market Access Issues
German medtech revenue growth has slowed, profit margins are being eroded, and exporters fear harsher US market access conditions on the return to office of President-Elect Donald Trump. The week became even more momentous with news of the collapse of the German government.
